Renacet®

Film-coated calcium acetate tablets
For hyperphosphataemia associated with chronic renal insufficiency in patients undergoing dialysis.1

Price
12% cost saving
Savings are based on NHS list prices for calcium acetate preparations on mg equivalence.2

Nice
1st line phosphate binder

“For adults, offer calcium acetate as the first line phosphate binder to control serum phosphate in addition to dietary management.”3


Choice
Two strengths 475/950mg tablets

Tablet size /strength allows tailoring to suit patient needs.

 

REFERENCES

1. Renacare NephroMed GmbH, Summary of Product Characteristics, Renacet 475mg and 950mg, film-coated tablets, December 2014.
2. MIMS Online accessed 20th January 2015
3. NICE Guideline CG157 March 2013 Hyperphosphataemia in chronic kidney disease. Management of hyperphosphataemia in patients with stage 4 or 5 chronic kidney disease

RESOURCES

Click here for more details and abbreviated prescribing information

Click here to download Summary of Product Characteristics Renacet 475mg

Click here to download Summary of Product Characteristics Renacet 950mg